Compound Evidence File
#EC-2026-0078
Thymosin Alpha-1
Filed under Peptides. The bureau holds 147 laboratory returns for this compound from 55 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
55 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Apr 2026 | 2 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Jan 2026 | 1 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Mar 2026 | 11 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 15 May 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Nov 2025 | 26 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Jan 2026 | 4 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Apr 2026 | 10 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 21 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Nov 2025 | 19 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Mar 2026 | 24 Mar 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 25 May 2026 | 20 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Apr 2026 | 27 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Feb 2026 | 9 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 9 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Jan 2026 | 6 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Feb 2026 | 3 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 20 Jul 2026 | 18 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 9.9 | 4 May 2026 | 16 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 9.9 | 27 Feb 2026 | 3 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Dec 2025 | 3 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Apr 2026 | 7 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 9.7 | 9.7 | 9.7 | 3 Jun 2025 | 3 Jun 2025 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 9.5 | 9.5 | 9.5 | 3 Jul 2025 | 3 Jul 2025 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 9.4 | 9.4 | 9.4 | 16 Mar 2025 | 16 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 9.1 | 8.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.9 | 8.0 | 9.6 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.6 | 7.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.3 | 6.9 | 9.3 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.2 | 7.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 5 | 8.2 | 7.6 | 9.0 | 14 Jan 2025 | 20 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 7 | 8.1 | 6.4 | 10.0 | 8 Jul 2025 | 25 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 | 21 May 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 7.9 | 7.0 | 9.4 | 21 May 2025 | 25 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 1 | 7.8 | 7.8 | 7.8 | 3 Jul 2025 | 3 Jul 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 7.2 | 5.9 | 8.4 | 27 Feb 2025 | 21 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 4 | 7.0 | 4.6 | 8.9 | 2 Apr 2025 | 21 May 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 | 9 Jun 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 6.5 | 6.5 | 6.5 | 27 Feb 2025 | 27 Feb 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 | 2 Jul 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 | 20 Jun 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 | 28 Mar 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 5.9 | 5.9 | 5.9 | 25 Apr 2025 | 25 Apr 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 5.7 | 4.3 | 6.7 | 8 Jul 2025 | 19 Jan 2026 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 4 | 5.3 | 4.6 | 5.7 | 8 Jul 2025 | 17 May 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 5.3 | 3.9 | 6.8 | 8 Jul 2025 | 21 May 2026 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 4.9 | 4.9 | 4.9 | 13 Feb 2025 | 13 Feb 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 4.5 | 4.5 | 4.5 | 13 Feb 2025 | 13 Feb 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 2.8 | 2.8 | 2.8 | 20 Jun 2025 | 20 Jun 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 2.0 | 2.0 | 2.0 | 24 Apr 2025 | 24 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 1.7 | 1.7 | 1.7 | 20 Jun 2025 | 20 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 1.5 | 1.5 | 1.5 | 2 Apr 2025 | 2 Apr 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 1.2 | 1.2 | 1.2 | 27 Feb 2025 | 27 Feb 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for Thymosin Alpha-1 alone.